There were 2,409 press releases posted in the last 24 hours and 440,376 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Verrica Pharmaceuticals Announces Receipt of Final FDA Minutes Following Type A Meeting Regarding Resubmission of the NDA for VP-102 in Molluscum

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image